| Previous | Volume 317 | July 23, 1987 | Number 4 | Next |
|---|
|
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial M. A. Fischl and Others Abstract
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial
Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution
Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis
The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease
Lead poisoning in automobile radiator mechanics
Current concepts: immunology. Idiotypes and idiotypic networks
Screening for HIV: can we afford the false positive rate?
Transfusion-associated hepatitis and AIDS. What is the risk?
Weekly clinicopathological exercises. Case 30-1987. A 43-year-old woman with breast cancer and the abrupt onset of respiratory failure
|
Growth factors in fibrotic diseases T. F. Deuel and R. M. Senior
Predictors of AIDS in homosexual men
Lymphadenopathy in asymptomatic patients seropositive for HIV
Activated T-lymphocyte subsets in Graves' disease
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin
Outcome assessment
Frequent-flyer programs for drug prescribing
|
[Note: This page was generated from the Medline data base.
There may be some discrepancies between the page shown and the original printed version.]
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |